Digital health startup M2S raises 2 billion won in pre-Series A funding

M2S, a digital healthcare company, announced on the 6th that it had raised ₩2 billion in pre-Series A funding. The investors included the Korea Credit Guarantee Fund and EnLight Ventures.

Founded in 2017, M2S is an ICT startup that develops and operates eye care services and platforms, including VROR, a VR-based eye examination device. The company holds 12 domestic and international patents related to eye examinations, including a foundational Korean patent for eye exams using VR and eye tracking.

M2S is using the investment to accelerate the development and commercialization of advanced eye examination algorithms and new technologies. It is also recruiting top talent in digital healthcare, including a former executive director at Osstem Implant as its chief technology officer (CTO).

M2S said the funding will further accelerate technology development to support its expansion into global digital healthcare markets. The company plans to launch I-care, an eye health management solution, in the second half of this year. It will then pursue partnerships with government agencies and global companies in the United States, the Middle East, and Southeast Asia.

M2S CEO Lee Tae-hwi said, “We’re pleased that, just three years after founding the company, our technology and products have been recognized for their capabilities and value. By bringing together M2S’s diverse expertise and technologies, we aim to grow into a world-class digital healthcare company representing Korea.”

M2S is also conducting joint research with Korea University and others to develop diagnostic devices for ear, nose, and throat conditions and brain disorders such as brain lesions. The company plans to build diagnostic and treatment platforms using artificial intelligence.